The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for LGC sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
LGC Ltd (LGC), a subsidiary of LGC Science Group Holdings Ltd, is a life sciences measurement and testing company that offers genomics solutions and quality assurance services. The company’s product portfolio include GMP and RUO oligonucleotides, molecular biology reagents, NGS (Next generation sequencing) kits and enzymes, sample prep reagents and instruments, PCR reagents and instruments, and oligo synthesis reagents and instruments, among others. Its products and services are used by a wide range of industries including biotechnology, pharmaceuticals, diagnostic labs, healthcare, animal breeders, seed producers and aquaculture, food and beverage, and government agencies and Research institutes and universities. The company through its subsidiaries operates across the UK. LGC is headquartered in Teddington, Middlesex, the UK. Key subsidiaries of LGC include Kova International, Rapid Genomics, MBH Analytical, BRC Trading and o2si smart solutions.
The key metrics of LGC related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As LGC is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as LGC.
For a detailed understanding of the performance of LGC, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
